Among the tissues and organs crucial in regulating glucose and lipid metabolism, pancreas, brain, and adipocytes express GIP receptors (GIPRs), while pancreas, brain, and gastrointestinal tract are rich in GLP-1 receptors (GLP-1Rs) (40)
A GLP-1 patch is a type of transdermal delivery system designed to administer GLP-1 medications through the skin
weight-loss pharmacotherapy may not be appropriate Gastrointestinal conditions, particularly gastroparesis or inflammatory bowel disease Thyroid disorders (report any symptoms such as neck swelling, difficulty swallowing, or hoarseness) Diabetes and current glycaemic control Cardiovascular conditions Any history of pancreatitis or gallbladder disease All current medications and supplements must be disclosed, as both Wegovy and escitalopram may interact with other medicines
Distinguishing tachyphylaxis from other explanations requires systematic evaluation
Monami, M., Dicembrini, I., Martelli, D
Medication review: could diabetes drugs change hypoglycemia risk
